Abstract
The development and use of effectwe sterility tests should be an essential part of the quality control program of any industry engaged in production and marketing of parenteral drugs. This presentation briefly outlines the sterility testing procedures employed by a typical field laboratory of the Food and Drug Administration (FDA) with particular emphasis on the control measures employed to ensure the validity of these tests. Problems which can be encountered with some of the techniques involved, particularly membrane filtration, are presented. A mutual understanding of the procedures employed by industry and FDA may provide both with a better insight into providing consumers with safer and effective drugs.
- Received December 23, 1983.
- Accepted May 18, 1984.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.